CN Stock MarketDetailed Quotes

300199 Hybio Pharmaceutical

Watchlist
  • 11.53
  • -0.03-0.26%
Trading Nov 5 09:52 CST
10.18BMarket Cap-27649P/E (TTM)

Hybio Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Raw material medicine113.11M44.23%
Preparation102.7M40.16%
Other business22.85M8.94%
Solid class10.31M4.03%
大消费品及其他3.53M1.38%
Customer peptide2.56M1.00%
Other656.76K0.26%
View all
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
多肽制剂、原料药等产品232.87M91.06%
Other business22.85M8.94%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic141.64M55.39%
Abroad114.08M44.61%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data